Clinical Trial Update: Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a mucoadhesive oral wound rinse to prevent and treat stomatitis in patients with ER- or PR-positive metastatic or locally recu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer
• Progesterone Receptor-positive Breast Cancer
• Stage Iiib Breast Cancer
• Stage Iiic Breast Cancer

Drugs mentioned

• Everolimus (everolimus)
• Mucoadhesive Oral Wound Rinse

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer | Phase 2 | Status: COMPLETED